IFN-γ represses IL-4 expression via IRF-1 and IRF-2

Immunity

Volumn 17, Issue 6, 2002, Pages 703-712

  Elser, Bernd ^a   Lohoff, Michael ^b   Kock, Sonja ^b   Giaisi, Marco ^a   Kirchhoff, Sabine ^a   Krammer, Peter H ^a   Li Weber, Min ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERLEUKIN 4;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; TH1 CELL; TH2 CELL;

EID: 18744386097     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00471-5     Document Type: Article

References (53)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. Arthur R.P., Mason D. T cells that help B cell responses to soluble antigen are distinguishable from those producing interleukin 2 on mitogenic or allogeneic stimulation. J. Exp. Med. 163:1986;774-786.
3. Bluyssen H.A.R., Durbin J.E., Levy D.E. ISGF3γ p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 7:1996;11-17.
4. Driggers P.H., Ennist D.L., Gleason S.L., Mak W.-H., Marks M.S., Levi B.-Z., Flanagan J.R., Appella E., Ouato K. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA. 87:1990;3743-3747.
5. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T., Howard M., Moore D.W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:1991;3444-3451.
6. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:1989;729-739.
7. Harada H., Willison K., Sakakibara J., Miyamoto M., Fujita T., Taniguchi T. Absence of type I IFN system in EC cells. transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated Cell. 63:1990;903-913.
8. Harada H., Takahashi E., Itoh S., Harada K., Hori T.A., Taniguchi T. Structure and regulation of the human interferon regulatory 1 (IRF-1) and IRF-2 genes. implications for a gene network in the interferon system Mol. Cell. Biol. 14:1994;1500-1509.
9. Ho I.-C., Hodge M.R., Rooney J.W., Glimcher L.H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell. 85:1996;973-983.
10. Ho I.-C., Lo D., Glimcher L.H. C-maf promotes Th2 and attenuates Th1 differentiation by both IL-4 dependent and independent mechanisms. J. Exp. Med. 188:1998;1859-1866.
11. Hochrein H., O'Keeffe M., Luft T., Vandenabeele S., Grumont R.J., Maraskovsky E., Shortman K. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:2000;823-834.
12. Hodge M.R., Ranger A.M., Charles de la Brousse F., Hoey T., Grusby M.J., Glimcher L.H. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity. 4:1996;397-405. a.
13. Hodge M.R., Chun H.J., Rengarajan J., Alt A., Lieberson R., Glimcher L.H. NFAT-driven interleukin-4 transcription potentiated by NIP45. Science. 274:1996;1903-1905. b.
14. Holtschke T., Löhler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.P., Gabriele L., Waring J.F.et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 87:1996;307-317.
15. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4:1996;313-319. a.
16. Kaplan M.H., Sun Y.L., Hoey T., Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:1996;174-177. b.
17. Kimura T., Kadokawa Y., Harada H., Matsumoto M., Sato M., Kashiwazaki Y., Tarutani M., Tan R.S.P., Takasugi T., Matsuyama T.et al. Essential and non-redundant roles of p48 (ISGF3γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells. 1:1996;115-124.
18. Kirchhoff S., Schaper F., Hauser H. Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res. 21:1993;2881-2889.
19. Kirchhoff S., Oumard A., Nourbakhsh M., Levi B.Z., Hauser H. Interplay between repressing and activating domains defines the transcriptional activity of IRF-1. Eur. J. Biochem. 267:2000;6753-6761.
20. Klas C., Debatin K.M., Jonker R.R., Krammer P.H. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:1993;625-630.
21. Kopf M., Le Gros G., Bachmann M., Lamers M.C., Bluethmann H., Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 362:1993;245-248.
22. Kuhn R., Rajewsky K., Muller W. Generation and analysis of interleukin-4 deficient mice. Science. 254:1991;707-710.
23. Li-Weber M., Eder A., Krafft-Czpa H., Krammer P.H. T cell-specific negative regulation of transcription of the human cytokine IL-4. J. Immunol. 148:1992;1913-1918.
24. Li-Weber M., Davydov I.V., Krafft H., Krammer P.H. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 153:1994;4122-4133.
25. Li-Weber M., Giasi M., Krammer P.H. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T-cell accessory molecule CD28. J. Biol. Chem. 273:1998;32460-32466.
26. Lohoff M., Ferrick D., Mittrucker H.W., Duncan G.S., Bischof S., Rollinghoff M., Mak T.W. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 6:1997;681-689.
27. Lohoff M., Duncan G.S., Ferrick D., Mittrucker H.W., Bischof S., Prechtl S., Rollinghoff M., Schmitt E., Pahl A., Mak T.W. Deficiency in the transcription factor interferon regulatory factor-2 (IRF-2) leads to severely compromised development of natural killer and T-helper cells. J. Exp. Med. 192:2000;325-335.
28. Lucey D.R., Clerici M., Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9:1996;532-562.
29. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183:1996;147-157.
30. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., Gately M.K. IL-12-deficient mice are defective in IFN production and type 1 cytokine responses. Immunity. 4:1996;471-481.
31. Mamane Y., Heylbroeck C., Cenin P., Algarte M., Servant M.J., LePage C., DeLuca C., Kwon H., Lin R., Hiscott J. Interferon regulatory factors. the next generation Gene. 237:1999;1-14.
32. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kündig T.M., Amakawa R., Kishihara K., Wakeham A. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:1993;83-97.
33. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell. 54:1988;903-913.
34. Mosmann T.R., Coffman R.L. TH1 and TH2 cells. different patterns of lymphokine secretion lead to different functional properties Annu. Rev. Immunol. 7:1989;145-173.
35. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
36. Nelson N., Kanno Y., Hong C., Contursi C., Fujita T., Fowlkes B.J., O'Connell E., Hu-Li J., Paul W.E., Jankovic D.et al. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-. 1(and IFN consensus sequence binding protein expression by T cell activation. J. Immunol. 156):1996;3711-3720.
37. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
38. Parekh B.S., Maniatis T. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-β promoter. Mol. Cell. 3:1999;125-129.
39. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell. 76:1994;241-251.
40. Romagnani S. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:1994;227-257.
41. Sharf R., Azriel A., Lejbkowicz F., Winograd S.S., Ehrlich R., Levi B.Z. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 270:1995;13063-13069.
42. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., Chu C., Quelle F.W., Nosaka T., Vignali D.A. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 380:1996;630-633.
43. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
44. Strahl-Bolsinger S., Hecht A., Luo K., Grunstein M. SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast. Genes Dev. 11:1997;83-93.
45. Szabo S.J., Dighe A.S., Gubler U., Murphy K. Regulation of the interleukin (IL)-12R 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817-824.
46. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman G.C., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100:2000;655-669.
47. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in IL-4 signalling. Nature. 380:1996;627-630.
48. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., Suzuki G., Mitsuyama M., Shin E.H., Kojima S.et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 6:1997;673-679.
49. Tanaka N., Taniguchi T. The interferon regulatory factors and oncogenesis. Semin. Cancer Biol. 10:2000;73-81.
50. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., Sangster M.Y., Vignali D.A., Donherty P.C., Grosveld G.C., Ihle J.N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 382:1996;171-174.
51. Vaughan P.S., Aziz F., van Wijnen A.J., Wu S., Harada H., Taniguchi T., Soprano K.J., Stein J.L., Stein G.S. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature. 377:1995;362-365.
52. Vaughan P.S., van der Meijden C., Aziz F., Jarada H., Taniguchi T., van Wijnen A., Stein J.L., Stein G.S. Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2. J. Biol. Chem. 273:1998;194-199.
53. Zheng W.-P., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 89:1997;587-596.